NCT04568811View on ClinicalTrials.gov

The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine

PHASE1CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

September 26, 2020

Primary Completion Date

October 25, 2020

Study Completion Date

September 11, 2021

Conditions
Adenovirus Type-5 Vectored COVID-19 Vaccine
Interventions
BIOLOGICAL

Adenovirus Type-5 Vectored COVID-19 Vaccine

Low dose adenovirus type-5 vectored COVID-19 vaccine (5E10 vp)

Trial Locations (1)

Unknown

A rehabilitation centre in Wuhan, Wuhan

All Listed Sponsors
lead

Jiangsu Province Centers for Disease Control and Prevention

NETWORK

NCT04568811 - The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine | Biotech Hunter | Biotech Hunter